Product image of Natalya (Desogestrel, Ethinylestradiol) supplied by GNH India

Natalya

Active Ingredient:
Desogestrel, Ethinylestradiol
Origin:
EU

Natalya (Desogestrel, Ethinylestradiol)

Desogestrel/Ethinylestradiol, the active ingredient in Natalya, is a combined oral contraceptive presented as a tablet for oral use. It works by inhibiting ovulation and altering cervical mucus and endometrial lining, thereby preventing fertilization and implantation in women of reproductive age who seek reliable pregnancy prevention.

GNH India supplies Natalya as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured products that meet EU regulatory standards. Our distribution network provides reliable logistics and regulatory support for global customers.

Manufacturer / TM Owner

Heaton K.S.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Natalya, a combined oral contraceptive, is indicated for hormonal contraception to prevent pregnancy.

  • Prevention of pregnancy: provides reliable contraception for women of childbearing age.
  • Menstrual cycle regulation: helps establish regular bleeding patterns.
  • Acne improvement: may reduce acne severity associated with hormonal fluctuations.

How It Works

  • Desogestrel/Ethinylestradiol exerts its contraceptive effect by suppressing the hypothalamic‑pituitary‑gonadal axis, reducing the secretion of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH). This inhibition prevents ovulation. In addition, the estrogen component stabilises the endometrial lining while the progestin component thickens cervical mucus, creating an environment hostile to sperm penetration and implantation.

Side Effects

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Breast tenderness: temporary soreness or swelling.
  • Headache: occasional tension‑type headache.
  • Spotting: irregular bleeding between periods.
  • Weight gain: modest fluid retention.
  • Mood changes: irritability or mild mood swings.

Serious or Rare Side Effects

  • Deep vein thrombosis: blood clot formation in deep veins.
  • Pulmonary embolism: clot migration to lung vessels.
  • Stroke: cerebrovascular accident risk.
  • Myocardial infarction: heart attack in susceptible individuals.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Liver tumor: rare hepatic adenoma development.

Precautions & Warnings

Before prescribing Natalya, clinicians should consider several safety factors.

  • Pregnancy contraindication: not for use in pregnancy (Category X).
  • Smoking restriction: avoid in women over 35 who smoke.
  • Cardiovascular risk: assess history of thromboembolism or clotting disorders.
  • Liver disease: use with caution in hepatic impairment.
  • Drug interaction review: evaluate concomitant medications that may affect efficacy.
  • Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Natalya may interact with several medicines; monitoring is essential.

Major Interactions (Avoid)

  • Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce contraceptive effectiveness.
  • Anticoagulants (e.g., warfarin): hormonal changes can alter clotting parameters.
  • Certain antiretrovirals (e.g., efavirenz): may diminish hormone levels.

Moderate Interactions (Monitor Closely)

  • Antifungals (e.g., ketoconazole): can increase hormone concentrations.
  • SSRIs (e.g., fluoxetine): may increase risk of bleeding.
  • St. John’s wort: may lower contraceptive efficacy.

Frequently Asked Questions

Natalya is a combined oral contraceptive containing desogestrel and ethinylestradiol. It is prescribed to prevent pregnancy in women of reproductive age by inhibiting ovulation and creating conditions that block fertilisation and implantation.

The desogestrel component suppresses the release of luteinising hormone and follicle‑stimulating hormone, preventing ovulation. Ethinylestradiol stabilises the endometrium and, together with desogestrel, thickens cervical mucus, making it difficult for sperm to reach an egg.

The dosing regimen for Natalya is determined by the prescribing healthcare professional. Typically, it is taken as a daily tablet following the specific cycle schedule indicated on the prescription label.

Natalya is contraindicated in pregnancy (Category X) and should not be started or continued if a woman becomes pregnant. Use during breastfeeding is generally discouraged because hormonal contraceptives can affect milk production and infant exposure.

To order Natalya, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Natalya contains desogestrel, a third‑generation progestin, which is associated with a lower incidence of androgenic side effects compared with some older progestins. Its efficacy in preventing pregnancy is comparable to other combined oral contraceptives, while the side‑effect profile may differ slightly.

Natalya tablets should be stored at ambient temperature, below 25 °C, in the original blister pack. Keep them away from moisture, heat and direct sunlight to maintain potency throughout the shelf life.

Nataly a is taken orally, usually once daily at the same time each day. The tablets are swallowed with water and should be started on the first day of the menstrual period or as directed by a healthcare provider.

Serious risks include venous thromboembolism, pulmonary embolism, stroke, myocardial infarction and severe allergic reactions. Women with a history of clotting disorders, smoking over age 35, or certain cardiovascular conditions should avoid use.

Natalya should not be used by women who are pregnant, have known or suspected breast cancer, have a history of thromboembolic disease, uncontrolled hypertension, severe liver disease, or who are smokers over 35 years of age.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Desogestrel, Ethinylestradiol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT